Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital

COVID-19 India: Monoclonal antibodies are identical copies of an antibody that targets one specific antigen. This treatment has previously been used to treat infections such as Ebola and HIV.

Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday. Dr Pooja Khosla, Senior Consultant, Department of Medicine, SGRH, said a 36-year-old healthcare worker with high-grade fever, cough, muscle pain, severe weakness and leucopenia (reduction in the number of white blood cells) was administered REGCov2 (Casirivimab and Imdevimab) on Tuesday, day 6 of the disease. "Patients with these symptoms rapidly progress towards moderate to severe stage. In this case, high fever persisted for five days and total leukocytes count dropped to 2,600. After we gave him monoclonal antibody therapy, his parameters improved within eight hours. The patient has been discharged," she said. Monoclonal antibodies are identical copies of an antibody that targets one specific antigen. This treatment has previously been used to treat infections such as Ebola and HIV.